The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study

被引：0
|
作者：
Alessia Melegaro
Valentina Marziano
Emanuele Del Fava
Piero Poletti
Marcello Tirani
Caterina Rizzo
Stefano Merler
机构：
[1] Bocconi University,Department of Social and Political Sciences
[2] Bocconi University,Carlo F. Dondena Centre for Research on Social Dynamics and Public Policy
[3] Center for Information and Communication Technology,undefined
[4] Bruno Kessler Foundation,undefined
[5] Department of Hygiene and Preventive Medicine,undefined
[6] ATS,undefined
[7] Department of Infectious Disease,undefined
[8] Istituto Superiore di Sanità,undefined
来源：
BMC Medicine | / 16卷
关键词：
Varicella; Chickenpox; Herpes zoster; Shingles; Vaccination; Italy; Cost-effectiveness; Modelling; Individual-based models; Demography; Immunisation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Cost-effectiveness of a herpes zoster vaccination program among the French elderly people
    Belchior, Emmanuel
    Levy-Bruhl, Daniel
    Le Strat, Yann
    Herida, Magid
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2378 - 2382
  • [22] Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness Analysis
    Phuc Le
    Michael B. Rothberg
    Journal of General Internal Medicine, 2017, 32 : 159 - 167
  • [23] The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales
    Edmunds, WJ
    Brisson, M
    Rose, JD
    VACCINE, 2001, 19 (23-24) : 3076 - 3090
  • [24] Health Impact and Cost-effectiveness Assessment for the Introduction of Universal Varicella Vaccination in Switzerland
    Heininger, Ulrich
    Pillsbury, Matthew
    Samant, Salome
    Lienert, Florian
    Guggisberg, Patrik
    Gani, Ray
    O'Brien, Elliott
    Pawaskar, Manjiri
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (06) : E217 - E221
  • [25] The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study
    Marziano, Valentina
    Poletti, Piero
    Guzzetta, Giorgio
    Ajelli, Marco
    Manfredi, Piero
    Merler, Stefano
    PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2015, 282 (1804)
  • [26] Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data
    Goldman, G. S.
    King, P. G.
    VACCINE, 2013, 31 (13) : 1680 - 1694
  • [27] The epidemiologic and economic impact of varicella and herpes zoster vaccination in South Korea: A mathematical modelling study
    Kim, Sol
    Choi, Jae-Ki
    Suh, Jiyeon
    Park, Sun Hee
    Lee, Jeehyun
    VACCINE, 2024, 42 (19) : 4046 - 4055
  • [28] Childhood varicella-zoster virus vaccination in Belgium Cost-effective only in the long run or without exogenous boosting?
    Bilcke, Joke
    van Hoek, Albert Jan
    Beutels, Philippe
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (04) : 812 - 822
  • [29] The impact of varicella vaccination on paediatric herpes zoster epidemiology: a Canadian population-based retrospective cohort study
    Ellen Rafferty
    Laura Reifferscheid
    Margaret L. Russell
    Stephanie Booth
    Lawrence W. Svenson
    Shannon E. MacDonald
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 2363 - 2370
  • [30] The impact of varicella vaccination on paediatric herpes zoster epidemiology: a Canadian population-based retrospective cohort study
    Rafferty, Ellen
    Reifferscheid, Laura
    Russell, Margaret L.
    Booth, Stephanie
    Svenson, Lawrence W.
    MacDonald, Shannon E.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (11) : 2363 - 2370
12345